Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate1 1The trial was designed and the manuscript was written by Dr. Andriulli. No pharmaceutical or private grants were searched for or made available for performing the present work.
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 2 (8) , 713-718
- https://doi.org/10.1016/s1542-3565(04)00295-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Short-term prophylactic prevention of post-ERCP pancreatitisGastrointestinal Endoscopy, 2003
- Comparison of Two Dosing Regimens of Gabexate in The Prophylaxis of Post-Ercp PancreatitisAmerican Journal of Gastroenterology, 2003
- Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trialGastrointestinal Endoscopy, 2002
- Grading ERCPs by degree of difficulty: a new concept to produce more meaningful outcome dataGastrointestinal Endoscopy, 2000
- Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysisGastrointestinal Endoscopy, 2000
- Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trialGastrointestinal Endoscopy, 1999
- Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis.Gut, 1997
- Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde CholangiopancreatographyNew England Journal of Medicine, 1996
- Complications of Endoscopic Biliary SphincterotomyNew England Journal of Medicine, 1996
- Endoscopic sphincterotomy complications and their management: an attempt at consensusGastrointestinal Endoscopy, 1991